PTC Delivers New AI Functionality for Software-Driven Product Development with New ALM Releases Life Science Investing
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS Patient Biotech Investing
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results Life Science Investing
Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome Life Science Investing
Stoke Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
